Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4520-2 is a short (20–24 nucleotide) non-coding RNA belonging to the microRNA class, which regulate gene expression post-transcriptionally by affecting both the stability and translation of messenger RNAs. MicroRNAs are transcribed as part of long primary transcripts, then processed by Drosha and Dicer enzymes to yield mature microRNA that is loaded into an RNA-induced silencing complex (RISC). The RISC-loaded microRNA recognizes target mRNAs through base pairing and primarily causes translational inhibition or destabilization of the mRNA. Specific information about the biological function or disease involvement of MIR4520-2 is lacking. Like other microRNAs, its primary role is presumed to be fine-tuning gene expression networks in human cells, but no unique or canonical pathophysiological function has been identified for this microRNA to date
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4520-2 (MIR4520-2).